GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hangzhou Alltest Biotech Co Ltd (SHSE:688606) » Definitions » Accounts Payable & Accrued Expense

Hangzhou Alltest Biotech Co (SHSE:688606) Accounts Payable & Accrued Expense : ¥208.9 Mil (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Hangzhou Alltest Biotech Co Accounts Payable & Accrued Expense?

Hangzhou Alltest Biotech Co's quarterly accounts payable & accrued expense increased from Mar. 2024 (¥204.2 Mil) to Jun. 2024 (¥283.4 Mil) but then declined from Jun. 2024 (¥283.4 Mil) to Sep. 2024 (¥208.9 Mil).

Hangzhou Alltest Biotech Co's annual accounts payable & accrued expense declined from Dec. 2021 (¥467.3 Mil) to Dec. 2022 (¥319.4 Mil) and declined from Dec. 2022 (¥319.4 Mil) to Dec. 2023 (¥191.1 Mil).

Hangzhou Alltest Biotech Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Hangzhou Alltest Biotech Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou Alltest Biotech Co Accounts Payable & Accrued Expense Chart

Hangzhou Alltest Biotech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial 30.79 145.06 467.28 319.40 191.06

Hangzhou Alltest Biotech Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 183.90 191.06 204.23 283.36 208.93

Hangzhou Alltest Biotech Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Hangzhou Alltest Biotech Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hangzhou Alltest Biotech Co Ltd (SHSE:688606) » Definitions » Accounts Payable & Accrued Expense
Comparable Companies
SZSE:300981 SHSE:688277 SHSE:605369 SZSE:002950 SZSE:300358 SHSE:688151 SHSE:603222 SHSE:688410 SZSE:301367 SHSE:603301 ISRG XPAR:EL BDX TSE:7741 XSWX:ALC WST OCSE:COLO B RMD TSE:4543 XSWX:STMN
Traded in Other Exchanges
N/A
Address
No. 550, Yinhai Street, Baiyang Street, Hangzhou Economic and Technological Development Zone, Building 3-5, Zhejiang Province, Hangzhou, CHN, 310018
Website
http://www.alltests.com.cn
Hangzhou Alltest Biotech Co Ltd is engaged in the research and development, production and sales of in vitro diagnostic reagents.
Executives
Fu Yan Ping senior management
Lu Wei Ke Directors, senior managers, core technical personn
Gao Fei Directors, senior managers, core technical personn

Hangzhou Alltest Biotech Co Headlines

No Headlines